Common <i>ABCB1</i> SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject-Reference-Cited by-同舟云学术

Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject

Published:2022 Issue:4 Volume:30 Page:212
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Hwang Jun Gi¹^ORCID,Jeong Sae Im¹^ORCID,Kim Yu Kyong¹^ORCID,Lee Yujin¹^ORCID,Ji Sang Chun²^ORCID,Lee SeungHwan²^ORCID,Park Min Kyu¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju 28644, Korea.

2. Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.

Funder

Chungbuk National University

Publisher

Korean Society for Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical)

Link

https://tcpharm.org/pdf/10.12793/tcp.2022.30.e23

Reference34 articles.

1. A New Initiative on Precision Medicine

2. Precision Medicine

3. US Department of Health and Human Services, Food and Drug Administration. Premarket evaluation in early-phase clinical studies and recommendations for labeling. Accessed March 25, 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-pharmacogenomics-premarket-evaluation-early-phase-clinical-studies-and-recommendations/

4. ICH. General principles for planning and design of multi-regional clinical trials E17. The International Council for Harmonisation 2017. Accessed February 9, 2021. https://www.ich.org/page/efficacy-guidelines

5. Commentary on ICH guideline on genomic sampling and data management‐enabling opportunities in drug development and patient treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure;Expert Review of Cardiovascular Therapy;2023-11-02

2. Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response;Molecular Biology Reports;2023-10-11

3. Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review;Terapevticheskii arkhiv;2023-10-11